Union Health Ministry enforces strict compliance with revised Schedule M norms for pharmaceutical products in India, cancelling non-compliant licenses.

Suspension of Kaysons Pharma medicines due to quality concerns, leading to deaths and government investigation for public safety.

Tragic deaths of children in Chhindwara due to Coldrif syrup prompt Madhya Pradesh to ban its sale statewide.